• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

On behalf of the Organizing Committee, we are delighted to welcome you to the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) to be held on 20-23 February 2019 in Berlin, Germany.

We invite you to be a part of the ATTD initiative, namely bringing together clinicians such as diabetologists, endocrinologists as well as pediatricians and family medicine practitioners, scientists, engineers, start-ups, investors, medical corporations, regulators and payers with the single goal to ameliorate the care of people with diabetes at the fastest possible pace. Over the past decade, tremendous changes occurred in the use of new technologies to treat and monitor patients with diabetes and the annual ATTD meetings have become the leading international forum to present and discuss these innovations.

Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as glucose sensors, closed-loop systems, artificial pancreas, advisors, devices for diabetic prevention, new insulin analogues and delivery systems and insulin pumps and more.

ATTD 2019 promises to be an outstanding event and we will be happy to greet you in the interesting city of Berlin.

Yours sincerely,

Professor Moshe Phillip | Professor Tadej Battelino

Conference Chairpersons

Moshe Phillip, Israel

Tadej Battelino, Slovenia

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Messe Berlin

CityCube Berlin

Messedamm 26

14055 Berlin

Submission Info

Participants interested in presenting an Oral or E-Poster presentation are invited to submit an abstract. All abstracts will undergo peer review by the Abstract Review Committee and may be accepted for Oral Presentation, E-Poster Presentation, Read by Title or rejected.

PRESENTATION TYPES AVAILABLE:

ORAL - refers to abstracts accepted for oral presentation at the podium in dedicated Oral Presentation Sessions. 

E-POSTER - electronic poster presentation on large screens in the E-Poster Area to be viewed during the Conference.  

E-POSTER DISCUSSION - refers to abstracts accepted for E-Poster Presentation, which will be assigned by the Abstract Review Committee, to be presented on large screens in the E-Poster Area at dedicated E-Poster sessions during break times.

E-Poster presenters who register by the early bird registration deadline will also be eligible to present a paper Poster at the Conference. Additional information will be sent to the submitters in due course.

All accepted abstracts will be published in the peer-reviewed journal Diabetes Technology & Therapeutics, published by Mary Ann Liebert, Inc., Publishers. 

The Journal is indexed in PubMed.

All ATTD 2019 Conference attendees will be given an 'access token' to receive 2 months' free access to the Journal online, including the entire journal archive, and an opportunity to subscribe at a discount.

Abstract submission deadline 2018-10-08

Rue François-Versonnex 7

1207 Geneva, Switzerland

Tel:  +41 22 908 0488

Fax: + 41 22 906 9140

E-mail: reg_attd19@kenes.com

Rue François-Versonnex 7

1207 Geneva, Switzerland

Tel:  +41 22 908 0488

Fax: + 41 22 906 9140

E-mail: reg_attd19@kenes.com